Bavarian Nordic's partner Eurofarma has submitted an application to Brazil's health authority Anvisa for approval of the chikungunya vaccine CHIKV VLP, targeting prevention in people aged 12 and above. This marks a key step in making the vaccine available in Brazil, a country heavily affected by chikungunya, which causes severe joint pain and chronic arthritis in many cases. The vaccine, already approved in the US, Europe, UK, Switzerland, and Canada, is a single-dose, non-infectious vaccine designed to quickly trigger immunity. Eurofarma will handle regulatory, commercialization, and distribution activities in Brazil, while Bavarian Nordic remains the producer. The approval process is expected to advance efforts to control chikungunya's spread and impact in the region.
Bicara Therapeutics is progressing its Phase 3 trial of ficerafusp alfa for head and neck cancer, expecting interim results by mid-2027 that could support accelerated approval. The company holds nearly $500 million in cash and securities, funding ope...
Mercury Systems reported a Q4 EPS of $0.37, slightly below analyst estimates of $0.38, but exceeded revenue expectations with $289.78 million, a 6.1% increase year-over-year. The company showed robust demand with record bookings of $660 million and a...
Klarna shares dropped 22.81% after cutting its earnings outlook and announcing leadership changes, raising investor concerns. Fabrinet's stock fell 19.38% despite strong quarterly results due to a broader sell-off in AI infrastructure stocks. Leverag...
ProPhase Labs' stock soared 506.62% to $27.48 following a 1-for-4 reverse stock split aimed at consolidating shares and boosting price per share. Other notable gainers include Inpixon (+113%), Super League Gaming (+82%) after a major Bitcoin investme...
American Airlines is bringing back seatback entertainment screens and adding premium seats to its narrowbody jets starting in 2028. This move responds to traveler demand, especially from younger passengers, and aims to close the profit gap with compe...
